These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fungal infections associated with malignancies, treatments, and AIDS. Benedict S; Colagreco J Cancer Nurs; 1994 Oct; 17(5):411-7. PubMed ID: 7954389 [TBL] [Abstract][Full Text] [Related]
3. The emerging fungal threat. Sternberg S Science; 1994 Dec; 266(5191):1632-4. PubMed ID: 7702654 [No Abstract] [Full Text] [Related]
4. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Singh N Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825 [TBL] [Abstract][Full Text] [Related]
5. [Role of opportunistic fungi in human pathological anatomy]. Khmel'nitskiĭ OK; Bykov VL Arkh Patol; 1987; 49(4):3-9. PubMed ID: 3300611 [TBL] [Abstract][Full Text] [Related]
6. Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis. Das S; Saha R; Dar SA; Ramachandran VG Mycopathologia; 2010 Dec; 170(6):361-75. PubMed ID: 20577905 [TBL] [Abstract][Full Text] [Related]
7. Management of mycoses in patients with hematologic disease and cancer -- review of the literature. Ruhnke M; Maschmeyer G Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913 [TBL] [Abstract][Full Text] [Related]
8. Treatment of fungal and other opportunistic infections in immunocompromised patients. Wade JC Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282 [TBL] [Abstract][Full Text] [Related]
9. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. Guarro J; Antolín-Ayala MI; Gené J; Gutiérrez-Calzada J; Nieves-Díez C; Ortoneda M J Clin Microbiol; 1999 Nov; 37(11):3751-5. PubMed ID: 10523593 [TBL] [Abstract][Full Text] [Related]
11. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients. Singh N; Heitman J Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015 [TBL] [Abstract][Full Text] [Related]
12. Treatment of opportunistic mycoses: how long is long enough? Singh N Lancet Infect Dis; 2003 Nov; 3(11):703-8. PubMed ID: 14592599 [TBL] [Abstract][Full Text] [Related]
13. Fungal infections in cancer patients: an escalating problem. Samonis G; Bafaloukos D In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339 [TBL] [Abstract][Full Text] [Related]
14. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases. Walsh TJ; Lee JW; Roilides E; Pizzo PA Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021 [TBL] [Abstract][Full Text] [Related]
15. Fungal infections in the compromised host. Bodey GP Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():61-70. PubMed ID: 3138371 [No Abstract] [Full Text] [Related]
16. [Mycotic infection in immunosuppressed patients. An anatomopathologic study]. Brocheriou C; Badillet G; Gluckman E; Kuffer R; de Roquancourt A; Verola O; D'Agay MF; Lesourd A Ann Pathol; 1990; 10(2):99-108. PubMed ID: 2189427 [TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of systemic fungal infections. Richardson M; Lass-Flörl C Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126 [TBL] [Abstract][Full Text] [Related]